Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons With and Without Significant Amyloid Plaques

Yanxi Chen, Yi Su, Jianfeng Wu, Kewei Chen, Alireza Atri, Richard J Caselli, Eric M. Reiman, Yalin Wang, for the Alzheimer’s Disease Neuroimaging Initiative

Journal of Alzheimer’s Disease, 2024

A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry

Wu J, Su Y, Chen Y, Zhu W, Reiman EM, Caselli RJ, Chen K, Thompson PM, Wang J, Wang Y

Journal of Alzheimer’s Disease, 2023

Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

Wu J, Su Y, Zhu W, Jalili Mallak N, Lepore N, Reiman EM, Caselli RJ, Thompson PM, Chen K, Wang Y, ADNI Group

Journal of Alzheimer’s Disease, 2022

Predicting Brain Amyloidosis with Plasma B-Amyloid42/40 and MRI-Based Morphometry Features

Wu J, Su Y, Thompson PM, Reiman EM, Caselli RJ, Chen K, Wang Y

IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI), Mar. 2022

Investigating the Effect of Tau Deposition and Apoe on Hippocampal Morphometry in Alzheimer’s Disease: A Federated Chow Test Model

Wu J, Su Y, Reiman EM, Caselli RJ, Chen K, Thompson PM, Wang J*, Wang Y*

 IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI), Mar. 2022

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology

Wu J, Dong Q, Zhang J, Su Y, Wu T, Caselli RJ, Reiman EM, Ye J, Lepore N, Chen K, Thompson PM, Wang, Y, ADNI Group,

Frontiers in Neuroscience, section Brain Imaging Methods, 2021

Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases

Wu J, Dong Q, Gui J, Zhang J, Su Y, Chen K, Thompson PM, Caselli RJ, Reiman EM, Ye J, Wang Y, ADNI Group

Frontiers in Neuroscience, section Brain Imaging Methods, 2021, In Press.